Due to the use of TNF blockers, which, despite being one of the main cytokines causing inflammation in autoimmune diseases, are also one of those responsible for maintaining the anti-T. gondii, we thought that there could be a reduction in the percentage of cells expressing IFN-γ and an increase in regulatory T profile cells; however, this did not occur. This evidence concerns the gene IFNG and autoimmune disease.